Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Combination of Empagliflozin and Linagliptin as Second-Line Therapy in Subjects With Type 2 Diabetes Inadequately Controlled on Metformin
PaperCitations, authors & open-access status
Combination of Empagliflozin and Linagliptin as Second-Line Therapy in Subjects With Type 2 Diabetes Inadequately Controlled on Metformin is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 294 citations, 2015 year and closed oa status.
294
Citations
2015
Year
closed
OA Status